A novel compound that inhibits the BAF chromatin remodeling complex causes regression in an animal model of the incurable cancer uveal melanoma.
Epigenica AB, the leader in epigenomic innovation, proudly announces the launch of the EpiFinder™ GenomePro product, ...
Emerging evidence highlights that epigenetic alterations—including DNA methylation, histone modification, and chromatin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback